BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:47 AM EDT
318.05quote price arrow up+4.60 (+1.47%)
Volume
27,338
Close
313.45quote price arrow up+29.45 (+10.37%)
Volume
4,782,653
52 week range
54.10 - 315.16

...

Loading . . .
  • Open289.00
  • Day High315.16
  • Day Low282.50
  • Prev Close313.45
  • 52 Week High315.16
  • 52 Week High Date07/28/21
  • 52 Week Low54.10
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap75.704B
  • Shares Out241.52M
  • 10 Day Average Volume4.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change284.51

KEY STATS

  • Open289.00
  • Day High315.16
  • Day Low282.50
  • Prev Close313.45
  • 52 Week High315.16
  • 52 Week High Date07/28/21
  • 52 Week Low54.10
  • 52 Week Low Date09/04/20
  • Market Cap75.704B
  • Shares Out241.52M
  • 10 Day Average Volume4.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change284.51

RATIOS/PROFITABILITY

  • EPS (TTM)5.33
  • P/E (TTM)58.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)1.987B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)2.957B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)23.21%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:2803:28
BioNTech's Ozlem Tureci on malaria vaccine development

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
492.22+5.97+1.23%
GMAB
Genmab A/S
44.74+0.69+1.57%
INCY
Incyte Corp
78.01+1.67+2.19%
CRL
Charles River Laboratories International Inc
399.62+6.87+1.75%
EXAS
Exact Sciences Corp
116.06+4.11+3.67%